Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ECL logo

Ecolab Inc (ECL)ECL

Upturn stock ratingUpturn stock rating
Ecolab Inc
$248.53
Delayed price
Profit since last BUY-0.21%
Strong Buy
upturn advisory
BUY since 15 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: ECL (3-star) is a STRONG-BUY. BUY since 15 days. Profits (-0.21%). Updated daily EoD!

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Strong Buy
Profit: 42.72%
Upturn Advisory Performance Upturn Advisory Performance4
Avg. Invested days: 72
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 3
Last Close 09/18/2024
Type: Stock
Today’s Advisory: Strong Buy
Profit: 42.72%
Avg. Invested days: 72
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 3
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance4

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 72.04B USD
Price to earnings Ratio 42.02
1Y Target Price 256.82
Dividends yield (FY) 0.91%
Basic EPS (TTM) 5.96
Volume (30-day avg) 871672
Beta 1.14
52 Weeks Range 155.16 - 253.09
Updated Date 09/18/2024
Company Size Large-Cap Stock
Market Capitalization 72.04B USD
Price to earnings Ratio 42.02
1Y Target Price 256.82
Dividends yield (FY) 0.91%
Basic EPS (TTM) 5.96
Volume (30-day avg) 871672
Beta 1.14
52 Weeks Range 155.16 - 253.09
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 10.95%
Operating Margin (TTM) 14.72%

Management Effectiveness

Return on Assets (TTM) 7.3%
Return on Equity (TTM) 21.8%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE 42.02
Forward PE 33.33
Enterprise Value 78996591303
Price to Sales(TTM) 4.61
Enterprise Value to Revenue 5.05
Enterprise Value to EBITDA 23.35
Shares Outstanding 284537984
Shares Floating 254085260
Percent Insiders 0.18
Percent Institutions 90.76
Trailing PE 42.02
Forward PE 33.33
Enterprise Value 78996591303
Price to Sales(TTM) 4.61
Enterprise Value to Revenue 5.05
Enterprise Value to EBITDA 23.35
Shares Outstanding 284537984
Shares Floating 254085260
Percent Insiders 0.18
Percent Institutions 90.76

Analyst Ratings

Rating 3.7
Target Price 195.5
Buy 4
Strong Buy 8
Hold 14
Sell 1
Strong Sell -
Rating 3.7
Target Price 195.5
Buy 4
Strong Buy 8
Hold 14
Sell 1
Strong Sell -

AI Summarization

Ecolab Inc.: A Comprehensive Stock Analysis

Company Profile

History and Background

Ecolab Inc. (ECL) was founded in 1923 in St. Paul, Minnesota, focusing on providing water treatment solutions. Over the years, Ecolab expanded its offerings to include cleaning and sanitizing products for various industries, including food service, healthcare, and hospitality. Today, Ecolab is a global leader in water, hygiene, and infection prevention solutions, serving over 3.3 million customer locations in more than 170 countries.

Business Areas

Ecolab operates through three business segments:

  • Global Industrial: Serves industrial customers with water treatment, cleaning, and sanitizing solutions.
  • Global Healthcare & Life Sciences: Provides infection prevention and cleaning solutions to healthcare facilities and life science companies.
  • Global Food & Beverage: Offers sanitation, hygiene, and food safety solutions to food and beverage processors and retailers.

Leadership and Corporate Structure

Chad Holliday serves as the current Chairman and CEO, with Michael Johanns as Lead Independent Director. The company follows a decentralized structure, with each business segment operating independently but collaborating on cross-functional projects.

Top Products and Market Share

Top Products

  • Nalco Water Treatment Solutions: Ecolab's flagship offering, providing water treatment solutions for industrial customers.
  • Performix Cleaning and Sanitizing Products: Disinfectants, cleaners, and degreasers for foodservice, healthcare, and hospitality industries.
  • Purell Hand Sanitizers: A leading brand in hand hygiene solutions.

Market Share

  • Global Water Treatment Market: Ecolab holds the #1 position with a market share exceeding 20%.
  • Global Institutional Cleaning Market: Ecolab ranks as the #2 player with a market share around 10%.
  • Global Food Hygiene Market: The company holds a market share of approximately 15%, ranking among the top players.

Product Performance and Competitiveness

Ecolab's products are recognized for their efficacy, innovation, and sustainability. The company invests heavily in R&D to stay ahead of the curve and address evolving customer needs. Compared to competitors, Ecolab benefits from its broad product portfolio, global reach, and strong customer relationships.

Total Addressable Market

Ecolab operates in a large and growing market. The global market for water and process treatment chemicals is estimated at over $100 billion, while the global cleaning and hygiene market is valued at around $80 billion. Ecolab's focus on diverse industries and solutions positions it well to capture a significant share of these markets.

Financial Performance

Recent Financial Performance

In 2022, Ecolab generated revenue of $17.5 billion, with a net income of $1.2 billion. Profit margins stood at 8.5%, and EPS was $5.05. The company's revenue has grown steadily over the past five years, with a slight dip in 2020 due to the pandemic.

Cash Flow and Balance Sheet

Ecolab maintains a strong cash flow position, generating over $1.5 billion in operating cash flow in 2022. The company's balance sheet is also healthy, with a debt-to-equity ratio of 0.7.

Dividends and Shareholder Returns

Dividend History

Ecolab has a consistent dividend payout history, having increased its dividend for 20 consecutive years. In 2023, the company's dividend yield was 1.2%.

Shareholder Returns

Over the past 5 and 10 years, Ecolab's total shareholder returns have significantly outperformed the S&P 500 Index.

Growth Trajectory

Historical Growth

Ecolab's revenue has grown at an average rate of 4% over the past five years. This moderate growth reflects the company's focus on organic growth and strategic acquisitions.

Future Projections

Analysts project that Ecolab's revenue will grow at a rate of 3-5% over the next five years, driven by increased demand for water treatment, hygiene, and infection prevention solutions in a post-pandemic environment.

Growth Initiatives

Ecolab is pursuing several growth strategies, including:

  • Expanding into emerging markets.
  • Launching new products and services.
  • Pursuing strategic acquisitions.
  • Enhancing digital capabilities.

Market Dynamics

Industry Trends

The water treatment, hygiene, and infection prevention markets are expected to experience steady growth in the coming years, driven by factors such as population growth, increasing awareness of hygiene and environmental sustainability, and stricter regulations.

Ecolab's Positioning

Ecolab is well-positioned to capitalize on these trends with its strong brand, global reach, and commitment to innovation and sustainability. The company's focus on providing solutions that address both environmental and economic concerns positions it favorably in a competitive landscape.

Competitors

  • Key Competitors:
    • Veolia Environnement (VIE)
    • Suez Environnement (SEVZF)
    • Diversey Holdings (DSEY)
    • Kimberly-Clark (KMB)
    • Clorox (CLX)
  • Market Share Comparison:
    • Ecolab: 20%
    • Veolia: 15%
    • Suez: 12%
    • Diversey: 10%
    • Others: 43%
  • Competitive Advantages and Disadvantages:
    • Ecolab's advantages include its broad product portfolio, global reach, strong customer relationships, and commitment to innovation.
    • Potential disadvantages include its exposure to economic downturns and regulatory changes.

Potential Challenges and Opportunities

Key Challenges

  • Supply chain disruptions and rising raw material costs.
  • Technological advancements could disrupt existing business models.
  • Increasing competition from regional and niche players.

Opportunities

  • Expanding into new markets and segments.
  • Developing innovative and sustainable products.
  • Pursuing strategic acquisitions and partnerships.

Recent Acquisitions (Last 3 Years)

Acquisition Year Price (USD Billion) Explanation
Purolite 2021 3.7 Enhanced resin technology and offerings for water purification, separation, and filtration.
ChampionX 2021 2.2 Expanded presence in the industrial and energy sectors, providing production and process optimization solutions.
Baker Hughes Industrial & Energy Chemicals Business 2020 5.4 Strengthened water treatment and chemical solutions for the oil and gas industry.

AI-Based Fundamental Rating: 8.5/10

Ecolab's strong financial performance, market leadership, and growth potential earn it a high AI-based fundamental rating. The company's commitment to innovation and sustainability further strengthens its outlook. However, potential challenges such as supply chain issues and competition warrant consideration.

Sources and Disclaimers

This analysis utilizes data from the company's website, financial statements, analysts' reports, and industry sources. This information should not be considered financial advice. Please consult a qualified financial advisor before making investment decisions.

Disclaimer

This analysis provides an overview of Ecolab Inc. based on publicly available information and should not be considered investment advice. The stock market is subject to inherent risks, and past performance does not guarantee future results. Before making any investment decisions, it is crucial to conduct your own research and consider your individual risk tolerance and financial goals.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Ecolab Inc

Exchange NYSE Headquaters Saint Paul, MN, United States
IPO Launch date 1988-01-05 CEO & Chairman of the Board Mr. Christophe Beck
Sector Basic Materials Website https://www.ecolab.com
Industry Specialty Chemicals Full time employees 48000
Headquaters Saint Paul, MN, United States
CEO & Chairman of the Board Mr. Christophe Beck
Website https://www.ecolab.com
Website https://www.ecolab.com
Full time employees 48000

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through three segments: Global Industrial; Global Institutional & Specialty; and Global Healthcare & Life Sciences. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. Its Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. The Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. In addition, the company provides pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments including education, life sciences, and healthcare customers. Further, it offers colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​